Abstract
The aim of this study is to explore the role of circCELF1/miR-636/DKK2 pathway in myocardial fibrosis (MF). RT-qPCR and western blot were used to detect the expression of circCELF1, miR-636, and DKK2 in activated cardiac fibroblasts (CFs) and the hearts of acute myocardial infarction (AMI) mice. The m6A level of DKK2 was detected by RIP and RT-qPCR. The regulation of circCELF1/miR-636/DKK2 pathway on CF viability, activation, apoptosis, and migration was verified by CCK-8, western blot, flow cytometry, and Transwell. Ang II induced downregulation of circCELF1 expression, while circCELF1 enhanced the expression of DKK2 by adsorbing miR-636. circCELF1 also reduced DKK2 m6A level by upregulating FTO expression, thereby inhibiting the binding of miR-636 to DKK2 and promoting DKK2 expression. Ang II promoted CF viability, activation, and migration through the circCELF1/miR-636/DKK2 pathway. Both miR-636 inhibitors and DKK2 effectively reduced MF and improved cardiac function in AMI mice.
Graphical abstract
Similar content being viewed by others
Abbreviations
- 3′ UTR:
-
3′ Untranslated region
- α-SMA:
-
α-Smooth muscle actin
- AGO2:
-
Argonaute2
- AMI:
-
Acute myocardial infarction
- Ang II:
-
Angiotensin II
- CFs:
-
Cardiac fibroblasts
- circRNAs:
-
Circular RNAs
- DKK2:
-
Dickkopf WNT signaling pathway inhibitor 2
- FTO:
-
Fat mass and obesity-associated protein
- HE:
-
Hematoxylin and Eosin
- m6A:
-
N6-methyladenosine
- METTL3:
-
Methyltransferase-like 3
- MF:
-
Myocardial fibrosis
- MI:
-
Myocardial infarction
- NF-κB:
-
Nuclear factor kappa-B
- VR:
-
Ventricular remodeling
- RIP:
-
RNA immunoprecipitation
- RIPA:
-
Radio immunoprecipitation assay buffer
- RT-qPCR:
-
Real-time quantitative PCR
- TGF-β:
-
Transforming growth factor-β
References
Mannucci, P. M., Lotta, L. A., & Peyvandi, F. (2010). Genome-wide association studies in myocardial infarction and coronary artery disease. Journal of Tehran University Heart Center, 5, 116–121.
Gronda, E., Sacchi, S., Benincasa, G., et al. (2019). Unresolved issues in left ventricular postischemic remodeling and progression to heart failure. Journal of Cardiovascular Medicine (Hagerstown, Md.), 20, 640–649. https://doi.org/10.2459/JCM.0000000000000834
Frangogiannis NG (2020) Cardiac fibrosis. Cardiovasc Res:cvaa324. https://doi.org/10.1093/cvr/cvaa324
Bayoumi, A. S., Aonuma, T., Teoh, J. P., et al. (2018). Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases. Acta Pharmacologica Sinica, 39, 1100–1109. https://doi.org/10.1038/aps.2017.196
Gu, X., Jiang, Y. N., Wang, W. J., et al. (2020). Comprehensive circRNA expression profile and construction of circRNA-related ceRNA network in cardiac fibrosis. Biomedicine & Pharmacotherapy, 125, 109944. https://doi.org/10.1016/j.biopha.2020.109944
Yin, L., Tang, Y., & Jiang, M. (2020). Research on the circular RNA bioinformatics in patients with acute myocardial infarction. Journal of Clinical Laboratory Analysis, 35, e23621. https://doi.org/10.1002/jcla.23621
Lin, F., Yang, Y., Guo, Q., et al. (2020). Analysis of the molecular mechanism of acute coronary syndrome based on circRNA-miRNA network regulation. Evid Based Complement Alternat Med, 2020, 1584052. https://doi.org/10.1155/2020/1584052
Miyamoto, S. D., Karimpour-Fard, A., Peterson, V., et al. (2015). Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy. Journal of Heart and Lung Transplantation, 34, 724–733. https://doi.org/10.1016/j.healun.2015.01.979
Bardin, P., Foussignière, T., Rousselet, N., et al. (2019). miR-636: A newly-identified actor for the regulation of pulmonary inflammation in cystic fibrosis. Frontiers in Immunology, 10, 2643. https://doi.org/10.3389/fimmu.2019.02643
Sun, L. Y., Bie, Z. D., Zhang, C. H., et al. (2016). MiR-154 directly suppresses DKK2 to activate Wnt signaling pathway and enhance activation of cardiac fibroblasts. Cell Biology International, 40, 1271–1279. https://doi.org/10.1002/cbin.10655
Liu, X. M., & Zhou, J. (2021). Multifaceted regulation of translation by the epitranscriptomic modification N6-methyladenosine. Critical Reviews in Biochemistry and Molecular Biology, 56, 137–148. https://doi.org/10.1080/10409238.2020.1869174
Qin, Y., Li, L., Luo, E., et al. (2020). Role of m6A RNA methylation in cardiovascular disease (Review). International Journal of Molecular Medicine, 46, 1958–1972. https://doi.org/10.3892/ijmm.2020.4746
Mathiyalagan, P., Adamiak, M., Mayourian, J., et al. (2019). FTO-dependent N6-methyladenosine regulates cardiac function during remodeling and repair. Circulation, 139, 518–532. https://doi.org/10.1111/jcmm.13185
Zhang, X., Xu, Y., Qian, Z., et al. (2018). circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma. Cell Death & Disease, 9, 1091. https://doi.org/10.1038/s41419-018-1132-6
Li, X., Xue, X., Sun, Y., et al. (2019). MicroRNA-326-5p enhances therapeutic potential of endothelial progenitor cells for myocardial infarction. Stem Cell Research & Therapy, 10, 323. https://doi.org/10.1186/s13287-019-1413-8
Zeng, Y., Du, W. W., Wu, Y., et al. (2017). A circular RNA binds to and activates AKT phosphorylation and nuclear localization reducing apoptosis and enhancing cardiac repair. Theranostics, 7, 3842–3855. https://doi.org/10.1161/CIRCULATIONAHA.118.036146
Zhou, B., & Yu, J. W. (2017). A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-β1. Biochemical and Biophysical Research Communications, 487, 769–775. https://doi.org/10.7150/thno.19764
Zhu, Y., Pan, W., Yang, T., et al. (2019). Upregulation of circular RNA CircNFIB attenuates cardiac fibrosis by sponging miR-433. Frontiers in Genetics, 10, 564. https://doi.org/10.1161/CIRCULATIONAHA.118.033794
Salem, A. M., Ragheb, A. S., Hegazy, M. G. A., et al. (2019). Caffeic acid modulates miR-636 expression in diabetic nephropathy Rats. Indian Journal of Clinical Biochemistry, 34, 296–303. https://doi.org/10.1016/j.bbrc.2017.04.044
Ji, J., Xu, Q., He, X., et al. (2020). MicroRNA microarray analysis to detect biomarkers of aortic dissection from paraffin-embedded tissue samples. Interactive Cardiovascular and Thoracic Surgery, 31, 239–247. https://doi.org/10.3389/fgene.2019.00564
Morishita, A., Yoneyama, H., Iwama, H., et al. (2018). Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir. Oncotarget, 9, 32054–32062. https://doi.org/10.1007/s12291-018-0743-0
Yanagida, A., Iwaisako, K., Hatano, E., et al. (2011). Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells. Biochimica et Biophysica Acta, 1812, 1403–1411. https://doi.org/10.1093/icvts/ivaa093
Hong, F., Hong, J., Wang, L., et al. (2015). Chronic exposure to nanoparticulate TiO2 causes renal fibrosis involving activation of the Wnt pathway in mouse kidney. Journal of Agricultural and Food Chemistry, 63, 1639–47. https://doi.org/10.18632/oncotarget.25889
Dorn, L. E., Lasman, L., Chen, J., et al. (2019). The N6-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy. Circulation, 139, 533–545. https://doi.org/10.1016/j.bbadis.2011.06.015
Funding
This work was supported by the Shandong Provincial Medical and Health Science and Technology Development Plan Project (2019WS119) and Ningxia Medical University Scientific Research Project (XY2017113).
Author information
Authors and Affiliations
Contributions
ZDB was responsible for conceiving the study. XXL was responsible for the experimental studies and manuscript preparation. BM and XL were responsible for the data acquisition and analysis.
Corresponding author
Ethics declarations
Ethics Approval
This study was approved by the Ethics Committee of Animal Research Institute of Xianyang Hospital of Yan'an University, and the experiment was performed in accordance with the guidelines of the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Consent to Participate
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Additional information
Associate Editor Joost Sluijter oversaw the review of this article
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, Xx., Mu, B., Li, X. et al. circCELF1 Inhibits Myocardial Fibrosis by Regulating the Expression of DKK2 Through FTO/m6A and miR-636. J. of Cardiovasc. Trans. Res. 15, 998–1009 (2022). https://doi.org/10.1007/s12265-022-10209-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-022-10209-0